SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-008094
Filing Date
2021-02-24
Accepted
2021-02-24 16:13:11
Documents
14
Period of Report
2021-02-24
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rcus-8k_20210224.htm   iXBRL 8-K 33845
2 EX-99.1 rcus-ex991_6.htm EX-99.1 261384
3 GRAPHIC gb1vtrwlrilo000001.jpg GRAPHIC 11418
  Complete submission text file 0001564590-21-008094.txt   454975

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA rcus-20210224.xsd EX-101.SCH 5776
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE rcus-20210224_lab.xml EX-101.LAB 18717
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rcus-20210224_pre.xml EX-101.PRE 11173
7 EXTRACTED XBRL INSTANCE DOCUMENT rcus-8k_20210224_htm.xml XML 3419
Mailing Address 3928 POINT EDEN WAY HAYWARD CA 94545
Business Address 3928 POINT EDEN WAY HAYWARD CA 94545 (510) 694-6200
Arcus Biosciences, Inc. (Filer) CIK: 0001724521 (see all company filings)

IRS No.: 473898435 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38419 | Film No.: 21673269
SIC: 2834 Pharmaceutical Preparations